IVIG: limited evidence and harms

Panel critiques IVIG use for BK/CMV, noting weak evidence, occasional benefit for antibody-mediated rejection, and rare harms.

Play episode from 36:59

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!